Page last updated: 2024-11-04

sulfasalazine and Elevated ICP (Intracranial Pressure)

sulfasalazine has been researched along with Elevated ICP (Intracranial Pressure) in 1 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Research Excerpts

ExcerptRelevanceReference
"Early diagnosis of intracranial hypertension is important in patients with ulcerative colitis receiving 5 ASA treatment to prevent visual complications."1.35Drug induced intracranial hypertension associated with sulphasalazine treatment. ( Kansu, T; Sevgi, E; Varli, K; Yalcin, G, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sevgi, E1
Yalcin, G1
Kansu, T1
Varli, K1

Other Studies

1 other study available for sulfasalazine and Elevated ICP (Intracranial Pressure)

ArticleYear
Drug induced intracranial hypertension associated with sulphasalazine treatment.
    Headache, 2008, Volume: 48, Issue:2

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Female; Headache; Humans; Intra

2008